NEW YORK (GenomeWeb News) – Genizon BioSciences has entered into a partnership with drug development consultancy Speid & Associates to offer that firm's clients access to Genizon's predictive techniques in the drug development process.

Speid's customers will use Genizon's genetic platform to identify and eliminate compounds that have a relatively low chance of success early in the drug development cycle.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.